This option will reset the home page of this site. Restoring any closed widgets or categories.

Reset
Home  »  Archives

Pharma News

Big Pharma Mergers: Good News Or Bad?

Written on 24 Nov, 2009 at 14:25 in Pharma News | viewed times | 0 Comments
Big Pharma Mergers: Good News Or Bad?

Whoever says you can’t throw money at problems hasn’t spent much time following the Big Pharma sector this year. More than $160 billion worth of buyouts involving top drugmakers has already been inked in 2009. The list of blockbuster deals includes... (Continue reading)

Drug makers pay millions to sway health debate

Written on 4 Nov, 2009 at 12:26 in Pharma News | viewed times | 1 Comment
Drug makers pay millions to sway health debate

Swiss pharmaceutical giants Roche and Novartis are spending millions of dollars in an effort to influence United States politicians tackling health care reform. The companies are among the top ten drug manufacturers lobbying the White House and Congress, having spent upwards... (Continue reading)

“Grosser Stress” für Roche-Informatiker

Written on 4 Nov, 2009 at 12:07 in Pharma News | viewed times | 1 Comment

Informatik der beiden Sparten Pharma und Diagnostika wird zusammengelegt. Umfang des Stellenabbaus noch unklar. Wie die ‘SonntagsZeitung’ gestern berichtete, plant der Basler Pharma-Riese Roche die Zusammenlegung der IT-Bereiche der beiden Divisionen Pharma und Diagnostika. Der Entscheid ist im September gefällt worden.... (Continue reading)

Can web 2.0 reboot clinical trials?

Written on 2 Nov, 2009 at 10:08 in Pharma News | viewed times | 2 Comments
Can web 2.0 reboot clinical trials?

Dozens of companies are trying to leverage social networking and other software tools to accelerate trials and reduce their cost. Enrolling patients in clinical trials is a perennial challenge for sponsors. One-third of trial sites fail to recruit a single patient... (Continue reading)

Stamford Life Sciences at PhUSE conference in Basel

Written on 19 Oct, 2009 at 14:17 in Frog Blog, Pharma News | viewed times | 2 Comments
Stamford Life Sciences at PhUSE conference in Basel

Stamford Consultants is an official partner of the 2009 PhUSE Conference. The 2009 conference will be held in Basel Switzerland between the 19th – 21st October. There is pre-conference training being held from 2pm on Sunday 18th October. PhUSE (Pharmaceutical... (Continue reading)

Big drug firms embrace generics

Written on 5 Oct, 2009 at 9:00 in Pharma News | viewed times | 1 Comment
Big drug firms embrace generics

Big pharmaceutical firms are learning to love their erstwhile enemies, makers of generic drugs. ONE recent evening, the most powerful man in the world posed an existential question to those around him. “If there’s a blue pill and a red pill,... (Continue reading)

Biotech startups turn to big pharma for survival

Written on 28 Sep, 2009 at 9:00 in Pharma News | viewed times | 1 Comment
Biotech startups turn to big pharma for survival

Money for startup biotechs sure is hard to come by in this economy. And that means more companies are being forced to consider being acquired in order to survive and bring their products to market. “Fairly new companies, particularly those in... (Continue reading)

Connecting with Customers in Digital Space

Written on 21 Sep, 2009 at 9:00 in Pharma News | viewed times | 0 Comments
Connecting with Customers in Digital Space

People wrestling with the challenges of digital marketing in the pharmaceutical world have realized there is no one-size-fits-all approach to success. Those who do it well have realized that each product’s audience has unique characteristics that require a specifically targeted... (Continue reading)

Growth in personalised medicine to drive alliances between diagnostic and pharmaceutical industries

Written on 14 Sep, 2009 at 9:00 in Pharma News | viewed times | 0 Comments
Growth in personalised medicine to drive alliances between diagnostic and pharmaceutical industries

The growth of personalised medicine, which aims to better target treatments to patients, is expected to increase the number of alliances between diagnostic and pharmaceutical businesses, according to a new PricewaterhouseCoopers (PwC) report entitled Diagnostics 2009: Moving towards personalised medicine. This... (Continue reading)

How pharma companies can be better long-term bets

Written on 7 Sep, 2009 at 9:00 in Pharma News | viewed times | 0 Comments
How pharma companies can be better long-term bets

Nothing ventured, nothing gained is a popular Spanish proverb elucidating that taking risk is a prerequisite for expecting any higher return. Unfortunately, that’s not always the case in the world of investing. At times, investors invest in companies which have... (Continue reading)

Despite downturn, Biopharmas boost R&D spending

Written on 31 Aug, 2009 at 11:06 in Pharma News | viewed times | 0 Comments
Despite downturn, Biopharmas boost R&D spending

Since Q4 2007, research spending in the U.S. has dropped 4 percent–or $1.9 billion. But report in BusinessWeek today lists 25 major U.S. corporations that, despite the economic downturn, have boosted R&D spending significantly in 2009. Of those 25, 13 were biotech and pharmaceutical companies,... (Continue reading)

Pharma Spotlight On – Biotech

Written on 31 Aug, 2009 at 9:00 in Pharma News | viewed times | 0 Comments
Pharma Spotlight On - Biotech

The U.S. biotechnology industry includes about 1,000 companies, of all sizes, with combined annual revenues close to $50 billion. Large companies include Amgen, Biogen Idec, Genetech, Genzyme, Life Technologies and Monsanto. Because so many drugs are now developed using biotechnology,... (Continue reading)

Will Lonza’s $460m Patheon offer trigger bidding war?

Written on 26 Aug, 2009 at 10:43 in Pharma News | viewed times | 0 Comments
Will Lonza's $460m Patheon offer trigger bidding war?

Canadian contractor Patheon has welcomed the $460m (€321m) takeover offer from Switzerland’s Lonza that could, according to some observers, spark a bidding war with rival suitor, US group JLL Patheon Holdings. Lonza’s bid, reported by Outsourcing-pharma on Friday, betters the unsolicited... (Continue reading)

Nycomed reports sustained momentum in second quarter 2009

Written on 24 Aug, 2009 at 10:54 in Pharma News | viewed times | 0 Comments
Nycomed reports sustained momentum in second quarter 2009

Nycomed reports sustained momentum in the second quarter 2009, with total net turnover increasing by 0.5% to €786.9 million excluding the impact of the Sepracor execution payment received in the first half of 2008. This performance is driven by Nycomed’s... (Continue reading)

Life sciences startups launching despite recession

Written on 24 Aug, 2009 at 9:00 in Pharma News | viewed times | 1 Comment
Life sciences startups launching despite recession

A handful of local life sciences companies have sprung to life over the past several months, in spite of a venture capital landscape that has sometimes looked windswept and barren. “The pace of deals is slower, but investors still have to... (Continue reading)

How Pharma industry can overcome its reservations of social networking

Written on 19 Aug, 2009 at 11:16 in Pharma News | viewed times | 0 Comments
How Pharma industry can overcome its reservations of social networking

Sticky or stuck? How the industry can overcome its reservations of social networking and forge new more open online relations with doctors. The 60’s philosopher and communications guru Marshall McLuhan said, “the medium is the message” and certainly the current buzz around... (Continue reading)

Contract research on the rise

Written on 10 Aug, 2009 at 11:59 in Pharma News | viewed times | 1 Comment
Contract research on the rise

The global economic crisis has got most businesses pinching pennies just to stay afloat, and the drug development industry is no exception. But at least one area of the biotechnology sector — contract research organizations (CROs) — is on the... (Continue reading)

Pharma Offers Bench-to-Bedside Opportunities

Written on 11 Jun, 2009 at 20:44 in Pharma News | viewed times | 0 Comments
Pharma Offers Bench-to-Bedside Opportunities

In 2003, Renee Commerford was approaching the end of her second postdoctoral appointment and staring out at an uncertain career in diabetes research. She had cast a broad net looking for a permanent job and had received offers from government... (Continue reading)

Why Drug Companies Prefer Twitter Over Blogs

Written on 21 May, 2009 at 22:38 in Pharma News | viewed times | 0 Comments
Why Drug Companies Prefer Twitter Over Blogs

GlaxoSmithKline has started a blog, becoming only the fourth* major drug company to launch an official unofficial voice on the web. The world of drug company blogs is a placid, uneventful place. According to John Mack’s PageFlakes site, where he collates... (Continue reading)

Advertisement